Publications by authors named "Wa Xie"

Claim this Profile
C
Comparing PD-L1 and PD-1 inhibitors plus bevacizumab combined with hepatic arterial interventional therapies in unresetable hepatocellular carcinoma: A single-center, real-world study.
Minrui He, Wa Xie, Ze Yuan, Jinbin Chen, Juncheng Wang

Int J Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential vs. concurrent systemic therapies in combination with FOLFOX-HAIC for locally advanced hepatocellular carcinoma: a single-center, real-world cohort study.
Liyang Sun, Zhiwen Hu, Wa Xie, Zhenyun Yang, Huilan Zeng

BMC Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative safety and efficacy of molecular-targeted drugs, immune checkpoint inhibitors, hepatic arterial infusion chemotherapy and their combinations in advanced hepatocellular carcinoma: findings from advances in landmark trials.
Yangxun Pan, Ruojing Wang, Dandan Hu, Wa Xie, Yizhen Fu

Front Biosci (Landmark Ed)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients.
Yang-Xun Pan, Xu-Qi Sun, Zi-Li Hu, Wa Xie, Ke-Xin Nie

J Hepatocell Carcinoma· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis